Asia-Pacific Osteoarthritis Therapeutics Market Size, Share, Growth, Trends, and Industry Analysis: By Disease Type (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, Others), By Drug Class (Viscosupplementation Agents, NSAIDs, Analgesics, Corticosteroids, Others), By Route of Administration (Oral, Topical, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Country Forecast 2020-2031

Asia-Pacific Osteoarthritis Therapeutics Market size was valued at US$ 8,208 million in 2024 and is expected to reach US$ 14,067 million by 2031, growing at a significant CAGR of 8.0% from 2025-2031. The market provides a detailed overview of the market, which has been segmented by disease type, drug class, route of administration, and distribution channel. The market has been segmented by disease type into Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and Others. The Knee Osteoarthritis segment is likely the most significant and fastest-growing segment in various disease types. The market has been segmented by drug class into Viscosupplementation Agents, NSAIDs, Analgesics, Corticosteroids, and Others. The Viscosupplementation Agents segment is expected to gain the maximum revenue share in the market over the forecast period 2024-2030. By route of administration, the market has been segmented into Oral, Topical, and Parenteral. The Parenteral segment accounted for the maximum revenue share. Based on the distribution channel, Asia-Pacific Osteoarthritis Therapeutics is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. According to precision business insights, the Hospital Pharmacies segment is predicted to register the fastest growth rate during the forecast period.

Key Developments:

• In August 2020, Dr. Reddy's Laboratories launched an over-the-counter Diclofenac Sodium topical gel used to treat arthritis pain in the US market.